Ignite Creation Date:
2024-05-05 @ 9:35 PM
Last Modification Date:
2024-10-26 @ 10:07 AM
Study NCT ID:
NCT00925223
Status:
UNKNOWN
Last Update Posted:
2009-10-14
First Post:
2009-06-18
Brief Title:
Brain-derived Neurotrophic Factor Participates in Visceral Hyperalgesia in Irritable Bowel Syndrome IBS Patients
Sponsor:
Shandong University
Organization:
Shandong University
Study Overview
Official Title:
Study of Brain-derived Neurotrophic Factor in Visceral Hyperalgesia in IBS Patients
Status:
UNKNOWN
Status Verified Date:
2009-10
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Brain-derived neurotrophic factor BDNF originally known to be a member of the nerve growth factor family has aroused attention as a modulator in visceral hyperalgesia recently Visceral hypersensitivity is recognized as a clinical hallmark in IBS patients So in this study the investigators will focus on the role of BDNF in colonic hyperalgesia in IBS patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NSFC30570831 | None | None | None |